FGF2 isoforms play distinct roles in tubular epithelial-to-mesenchymal transition in diabetic nephropathy

Exp Cell Res. 2022 Nov 15;420(2):113355. doi: 10.1016/j.yexcr.2022.113355. Epub 2022 Sep 15.

Abstract

Introduction: The role of different isoforms of Fibroblast growth factor-2 (FGF2) in tubular epithelial-to-mesenchymal transition (EMT) in diabetic nephropathy remains unknown. We aimed to evaluate the role of FGF2 isoforms in the pathogenesis of EMT.

Materials and methods: Western blot and immunofluorescence were used to assess the expression of FGF2 isoforms in db/db mice and high glucose-stimulated HK2 cells. The effects of specific FGF2 isoforms on EMT were explored via overexpression or knockdown of the corresponding isoform in HK2 cells cultivated in high glucose.

Results: Expression of low molecular weight (LMW) FGF2 was up-regulated while high molecular weight (HMW) FGF2 was down-regulated in the kidney of db/db mice and HK2 cells cultured in high glucose that underwent EMT. Overexpression of the LMW FGF2 enhanced EMT changes, while overexpression of the HMW FGF2 attenuated EMT. Knockdown of HMW FGF2 in HK2 cells promoted the EMT process.

Conclusions: The expression and function of LMW and HMW FGF2 differed in the process of EMT in tubular cells. LMW FGF2 contributed to EMT, while HMW FGF2 played a protective role in the EMT process.

Keywords: Db/db; Diabetic nephropathy; Epithelial-to-mesenchymal transition; FGF2 isoforms; HK2 cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diabetes Mellitus*
  • Diabetic Nephropathies* / genetics
  • Diabetic Nephropathies* / pathology
  • Epithelial-Mesenchymal Transition / genetics
  • Fibroblast Growth Factor 2 / genetics
  • Glucose / pharmacology
  • Mice
  • Protein Isoforms / genetics

Substances

  • Protein Isoforms
  • Fibroblast Growth Factor 2
  • Glucose